News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
Announcements
September 12, 2023
Repligen Appoints Jason K. Garland as Chief Financial Officer
Announcements
September 1, 2023
Repligen Corporation to Present at Wells Fargo Healthcare Conference
Announcements
August 17, 2023
Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification
Announcements
May 31, 2023
Repligen Corporation to Present at Upcoming Investor Conferences
Announcements
March 14, 2023
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
Announcements
March 13, 2023
RoosterBio and Repligen Collaborate to Advance Scalable Exosome Bioprocessing
Announcements
February 9, 2023
Repligen Appoints Martin D. Madaus to Board of Directors
Announcements
September 19, 2022
Repligen Expands Process Analytics Portfolio with DRS Daylight Solutions Agreement.
Announcements
February 15, 2022
Repligen Launches AAV Affinity Resins for Gene Therapy Purification
Announcements
December 16, 2021
Repligen Acquires BioFlex Solutions, LLC
Announcements
November 5, 2021
Repligen Releases Inaugural Sustainability Report
Announcements
September 16, 2021